
  
    
      
        Background_NNP
        DNA_NN microarrays_NNS have_VBP been_VBN widely_RB adopted_VBN in_IN genomics_NNS
        because_IN of_IN the_DT their_PRP$ ability_NN to_TO simultaneously_RB examine_VB the_DT
        expression_NN levels_NNS of_IN thousands_NNS of_IN genes_NNS ._. As_IN a_DT result_NN ,_, the_DT
        scope_NN of_IN applications_NNS for_IN microarrays_NNS has_VBZ broadened_VBN
        rapidly_RB ,_, from_IN drug_NN discovery_NN [_NN 1_CD ]_NN ,_, to_TO classification_NN of_IN
        cancers_NNS [_NN 2_CD 3_CD 4_CD ]_NN and_CC analysis_NN of_IN splice_NN variants_NNS [_NN 5_CD ]_NN ._.
        Novel_NNP analytical_JJ tools_NNS have_VBP been_VBN constructed_VBN to_TO address_VB
        every_DT component_NN of_IN the_DT microarray_NN experiment_NN and_CC optimize_NN
        performance_NN [_NN 6_CD ]_NN ._. However_RB ,_, ideal_JJ systems_NNS with_IN maximized_JJ
        sensitivity_NN and_CC data_NNS reproducibility_NN have_VBP not_RB been_VBN
        achieved_VBN ._. One_CD approach_NN to_TO enhance_VB sensitivity_NN in_IN
        microarrays_NNS ,_, using_VBG a_DT novel_NN signal_NN amplification_NN technique_NN ,_,
        has_VBZ recently_RB been_VBN reported_VBN [_NN 7_CD ]_NN ._. Another_DT approach_NN is_VBZ to_TO
        increase_VB the_DT affinity_NN of_IN a_DT probe_NN (_( nucleic_JJ acid_NN present_JJ on_IN
        the_DT array_NN )_) for_IN its_PRP$ target_NN through_IN modifications_NNS to_TO the_DT
        length_NN [_NN 8_CD ]_NN ,_, chemistry_NN [_NN 9_CD ]_NN ,_, or_CC physical_JJ structure_NN [_NN 10_CD
        ]_NN of_IN the_DT probe_NN ._.
        Naturally_RB occurring_VBG analogs_NNS of_IN purine_NN and_CC pyrimidine_NN
        bases_NNS have_VBP been_VBN examined_VBN extensively_RB for_IN their_PRP$ ability_NN to_TO
        increase_VB the_DT thermodynamic_JJ stability_NN of_IN DNA_NNP :_: DNA_NNP and_CC DNA_NNP :_: RNA_NNP
        duplexes_NNS [_NN 11_CD 12_CD 13_CD 14_CD 15_CD ]_NN ._. Among_IN these_DT are_VBP
        2_CD -_: aminoadenine_NN also_RB known_VBN as_IN diaminopurine_NN (_( DAP_NNP )_) ,_, which_WDT is_VBZ
        found_VBN in_IN S-_NNP 2_CD L_NNP cyanophage_NN DNA_NNP [_NN 16_CD ]_NN ,_, 5_CD -_: methyl_NN uracil_NN
        (_( MeU_NNP )_) ,_, and_CC 5_CD -_: methyl_NN cytidine_NN (_( MeC_NNP )_) ._. Previous_JJ studies_NNS have_VBP
        shown_VBN the_DT ribonucleoside_NN triphosphate_NN derivatives_NNS of_IN
        modified_VBN bases_NNS to_TO be_VB effectively_RB incorporated_VBN by_IN RNA_NNP
        polymerases_NNS [_NN 17_CD 18_CD ]_NN ,_, which_WDT make_VBP them_PRP an_DT excellent_JJ
        substrate_NN for_IN use_NN in_IN microarray_NN sample_NN preparations_NNS
        requiring_VBG amplification_NN through_IN 
        in_IN vitro_NN transcriptions_NNS (_( IVTs_NNP )_) ._.
        Due_JJ to_TO their_PRP$ effects_NNS on_IN duplex_NN stability_NN and_CC secondary_JJ
        structures_NNS and_CC their_PRP$ lack_NN of_IN replication_NN by_IN DNA_NNP
        polymerases_NNS ,_, modified_VBN nucleotides_NNS have_VBP recently_RB been_VBN
        exploited_VBN in_IN a_DT variety_NN of_IN technologies_NNS in_IN molecular_JJ biology_NN
        and_CC genomics_NNS ._. For_IN example_NN ,_, 2_CD '_POS -_: O-_NNP methyl_NN ribonucleotides_NNS and_CC
        5_CD -_: (_( 1_CD -_: propynyl_NN )_) pyrimidines_NNS have_VBP been_VBN chemically_RB incorporated_VBN
        into_IN oligonucleotides_NNS which_WDT were_VBD used_VBN to_TO detect_VB telomeric_JJ
        repeat_NN sequences_NNS in_IN fluorescence_NN 
        in_IN situ_NN hybridization_NN (_( FISH_NNP )_) assays_NNS [_NN
        19_CD ]_NN ._. Furthermore_RB ,_, chimeric_JJ primers_NNS containing_VBG
        deoxynucleotides_NNS and_CC 2_CD '_POS -_: O-_NNP methyl_NN ribonucleotides_NNS have_VBP been_VBN
        used_VBN to_TO eliminate_VB artifacts_NNS ,_, produced_VBN by_IN exponential_NN
        amplification_NN of_IN minor_JJ side-products_JJ ,_, in_IN cycle_NN sequencing_VBG [_NN
        20_CD ]_NN ._.
        Recently_RB ,_, studies_NNS employing_VBG DNA_NNP arrays_NNS have_VBP also_RB
        examined_VBN the_DT use_NN of_IN modified_VBN nucleotides_NNS such_JJ as_IN DAP_NNP ,_,
        5_CD -_: bromodeoxyuridine_NN ,_, and_CC 2_CD '_POS -_: O-_NNP methylthymidine_NN in_IN the_DT probe_NN
        [_NN 21_CD 22_CD ]_NN ._. An_DT alternative_JJ method_NN to_TO increase_VB the_DT
        probe-target_JJ affinity_NN is_VBZ to_TO incorporate_VB the_DT modified_VBN
        ribonucleotide_NN ,_, as_IN the_DT triphosphate_NN derivative_JJ ,_, during_IN the_DT
        IVT_NNP process_NN so_IN that_IN the_DT cRNA_NN produced_VBN has_VBZ the_DT desired_VBN level_NN
        of_IN substitution_NN of_IN the_DT corresponding_JJ unmodified_JJ nucleotide_NN ._.
        Such_JJ an_DT approach_NN has_VBZ been_VBN demonstrated_VBN in_IN a_DT study_NN which_WDT
        applied_VBD these_DT modified_VBN cRNA_NN products_NNS to_TO high_JJ density_NN
        oligonucleotide_NN arrays_NNS [_NN 23_CD ]_NN ._. However_RB ,_, that_DT study_NN
        measured_VBD the_DT signal_NN when_WRB amplifying_VBG a_DT specific_JJ gene_NN rather_RB
        than_IN a_DT genome-wide_JJ approach_NN ._. A_DT genome-wide_JJ amplification_NN ,_,
        coupled_VBN with_IN the_DT incorporation_NN of_IN modified_VBN nucleotides_NNS ,_,
        permits_VBZ measurement_NN of_IN every_DT transcript_NN in_IN the_DT sample_NN ._. To_TO
        our_PRP$ knowledge_NN ,_, no_DT systematic_JJ studies_NNS have_VBP been_VBN performed_VBN
        examining_VBG the_DT incorporation_NN of_IN modified_VBN ribonucleotide_NN
        triphosphates_NNS into_IN cRNA_NN ,_, yield_NN of_IN amplified_VBN material_NN ,_,
        effects_NNS on_IN hybridization_NN intensities_NNS and_CC reproducibility_NN ,_,
        and_CC the_DT impact_NN on_IN the_DT differential_NN expression_NN ratios_NNS ._. It_PRP
        will_MD not_RB be_VB possible_JJ to_TO gauge_VB the_DT full_JJ potential_NN ,_,
        advantages_NNS ,_, and_CC disadvantages_NNS until_IN such_JJ studies_NNS have_VBP been_VBN
        completed_VBN ._.
        In_IN this_DT study_NN ,_, we_PRP investigated_VBD the_DT possibility_NN that_DT
        incorporation_NN of_IN modified_VBN nucleotides_NNS into_IN complementary_JJ
        RNA_NNP (_( cRNA_NN )_) target_NN samples_NNS could_MD increase_VB signal_NN intensity_NN
        on_IN the_DT Motorola_NNP Codelink_NNP ™_NN Expression_NNP microarray_NN platform_NN ._.
        The_DT ratios_NNS of_IN modified_VBN to_TO unmodified_JJ nucleoside_NN
        triphosphates_NNS (_( NTPs_NNP )_) were_VBD varied_VBN in_IN each_DT target_NN synthesis_NN
        in_IN order_NN to_TO measure_VB the_DT range_NN of_IN effects_NNS on_IN cRNA_NN yield_NN ,_,
        specific_JJ activity_NN of_IN target_NN sample_NN ,_, hybridization_NN signals_NNS ,_,
        and_CC differential_NN expression_NN ratios_NNS ._. Our_PRP$ results_NNS suggest_VBP
        that_DT incorporation_NN of_IN 2_CD -_: aminoadenosine_NN (_( DAP_NNP )_) triphosphate_NN
        into_IN target_NN cRNA_NN samples_NNS may_MD increase_VB hybridization_NN signal_NN
        intensity_NN for_IN a_DT wide_JJ variety_NN of_IN RNA_NNP :_: DNA_NNP hybrid_JJ duplexes_NNS ._. In_IN
        contrast_NN ,_, 5_CD -_: methyluridine_NN and_CC 5_CD -_: methylcytidine_NN had_VBD
        detrimental_JJ effects_NNS on_IN signal_NN intensities_NNS ._. Hybridization_NNP
        specificity_NN was_VBD dependent_JJ on_IN both_DT target_NN sequence_NN and_CC
        extent_NN of_IN substitution_NN with_IN the_DT modified_VBN nucleotide_NN ._.
        Concurrent_JJ incorporation_NN of_IN modified_VBN and_CC unmodified_JJ ATP_NNP in_IN
        a_DT 1_CD :_: 1_CD ratio_NN resulted_VBD in_IN significantly_RB greater_JJR numbers_NNS of_IN
        above-threshold_JJ ratio_NN calls_VBZ across_IN tissues_NNS ,_, while_IN
        preserving_VBG ratio_NN integrity_NN and_CC reproducibility_NN ._.
      
      
        Results_NNS
        
          Effect_NN of_IN modified_VBN nucleotides_NNS on_IN cRNA_NN yield_NN and_CC
          assessment_NN of_IN their_PRP$ incorporation_NN and_CC biotin-_NN 11_CD -_: UTP_NNP
          incorporation_NN
          Although_IN DAP_NNP ,_, MeC_NNP ,_, and_CC MeU_NNP were_VBD tolerated_JJ by_IN T_NN 7_CD RNA_NNP
          polymerase_NN ,_, incorporation_NN of_IN these_DT analogs_NNS into_IN our_PRP$ IVT_NNP
          reaction_NN cocktails_NNS reduced_VBD the_DT yields_NNS of_IN amplified_VBN cRNA_NN ._.
          The_DT magnitude_NN of_IN the_DT decrease_NN was_VBD 20_CD -_: 30_CD %_NN and_CC depended_VBD on_IN
          RNA_NNP tissue_NN source_NN and_CC the_DT NTP_NNP modification_NN ._. However_RB ,_,
          within_IN the_DT context_NN of_IN our_PRP$ pre-established_JJ assay_NN
          conditions_NNS (_( a_DT single_NN color_NN ,_, single_JJ sample_NN per_IN array_NN
          system_NN using_VBG ten_CD micrograms_NNS of_IN cRNA_NN )_) ,_, enough_JJ cRNA_NN was_VBD
          generated_VBN from_IN each_DT IVT_NNP reaction_NN to_TO perform_VB
          hybridizations_NNS in_IN triplicate_NN ._. Thus_RB ,_, we_PRP were_VBD able_JJ to_TO
          normalize_VB input_NN amounts_NNS of_IN cRNA_NN for_IN each_DT condition_NN tested_VBN
          in_IN order_NN to_TO quantitatively_RB compare_VB relative_JJ changes_NNS due_JJ
          to_TO each_DT respective_JJ modification_NN ._. In_IN these_DT experiments_NNS ,_, we_PRP
          generated_VBD cRNA_NN from_IN five_CD micrograms_NNS of_IN total_JJ RNA_NNP and_CC did_VBD
          not_RB explore_VB the_DT impact_NN on_IN yield_NN when_WRB smaller_JJR or_CC larger_JJR
          amounts_NNS of_IN input_NN total_JJ RNA_NNP are_VBP used_VBN ._.
          We_PRP next_RB determined_VBN how_WRB well_RB the_DT modified_VBN NTPs_NNP were_VBD
          incorporated_VBN by_IN the_DT T_NN 7_CD RNA_NNP polymerase_NN and_CC whether_IN
          incorporation_NN of_IN biotinylated_JJ UTP_NNP was_VBD altered_VBN due_JJ to_TO the_DT
          presence_NN of_IN these_DT modified_VBN NTPs_NNP ._. To_TO address_VB these_DT
          questions_NNS ,_, we_PRP used_VBD an_DT analytical_JJ method_NN developed_VBN in_IN our_PRP$
          laboratory_NN and_CC described_VBD in_IN a_DT previous_JJ study_NN [_NN 24_CD ]_NN ._.
          Briefly_NNP ,_, the_DT complex_JJ cRNA_NN is_VBZ digested_VBN with_IN P_NN 1_CD nuclease_NN
          and_CC calf_NN intestinal_NN phosphatase_NN and_CC applied_VBN to_TO a_DT high_JJ
          performance_NN liquid_JJ chromatography_NN (_( HPLC_NNP )_) column_NN to_TO
          separate_VB the_DT nucleosides_NNS ,_, followed_VBN by_IN an_DT absorbance_NN
          measurement_NN at_IN 260_CD nm_NN ._. As_IN seen_VBN in_IN Figure_NN 1_CD A_DT ,_, when_WRB only_RB
          the_DT unmodified_JJ NTPs_NNP are_VBP incorporated_VBN during_IN the_DT IVT_NNP ,_,
          there_EX is_VBZ good_JJ separation_NN of_IN the_DT individual_JJ nucleosides_NNS ._.
          Furthermore_RB ,_, as_IN reported_VBN earlier_JJR [_NN 24_CD ]_NN ,_, using_VBG the_DT
          extinction_NN coefficients_NNS and_CC integrating_VBG the_DT area_NN under_IN
          these_DT peaks_NNS ,_, there_EX are_VBP approximately_RB equal_JJ amounts_NNS of_IN
          each_DT of_IN the_DT four_CD nucleosides_NNS ._. When_WRB DAP_NNP was_VBD added_VBN at_IN a_DT 1_CD :_: 1_CD
          molar_NN ratio_NN to_TO the_DT adenosine_NN ,_, the_DT chromatogram_NN showed_VBD
          incorporation_NN of_IN DAP_NNP into_IN the_DT cRNA_NN ,_, and_CC this_DT level_NN of_IN
          incorporation_NN appeared_VBD to_TO be_VB equivalent_JJ to_TO the_DT level_NN of_IN
          incorporation_NN of_IN adenosine_NN (_( Figure_NN 1_CD B_NNP )_) ._. Moreover_RB ,_, when_WRB
          the_DT adenosine_NN was_VBD fully_RB substituted_VBN by_IN the_DT DAP_NNP in_IN the_DT IVT_NNP
          reaction_NN cocktail_NN ,_, only_RB a_DT peak_NN corresponding_JJ to_TO the_DT DAP_NNP
          was_VBD detected_VBN (_( Figure_NN 1_CD C_NNP )_) ,_, and_CC this_DT peak_NN was_VBD approximately_RB
          equal_JJ in_IN area_NN to_TO that_DT of_IN the_DT adenosine_NN in_IN the_DT control_NN
          situation_NN ._. Similarly_RB ,_, when_WRB MeC_NNP was_VBD fully_RB substituted_VBN for_IN
          cytidine_NN in_IN the_DT IVT_NNP reaction_NN cocktail_NN ,_, only_RB a_DT peak_NN
          corresponding_JJ to_TO the_DT MeC_NNP was_VBD detected_VBN (_( Figure_NN 1_CD D_NNP )_) ,_, and_CC
          this_DT peak_NN was_VBD approximately_RB equal_JJ in_IN area_NN to_TO that_DT of_IN the_DT
          cytidine_NN in_IN the_DT control_NN situation_NN ._. In_IN contrast_NN ,_, we_PRP were_VBD
          unable_JJ to_TO examine_VB incorporation_NN levels_NNS of_IN the_DT MeU_NNP because_IN
          the_DT MeU_NNP peak_NN was_VBD eluted_JJ at_IN approximately_RB the_DT same_JJ time_NN as_IN
          the_DT guanosine_NN peak_NN (_( data_NNS not_RB shown_VBN )_) ._. It_PRP is_VBZ important_JJ to_TO
          note_VB that_IN these_DT analyses_NNS used_VBD the_DT complex_JJ cRNA_NN and_CC
          represent_VB a_DT global_JJ ,_, average_JJ view_NN of_IN the_DT incorporation_NN ._.
          Incorporation_NNP may_MD differ_VB somewhat_RB depending_VBG on_IN the_DT
          sequence_NN ,_, structure_NN ,_, or_CC expression_NN level_NN of_IN the_DT nascent_NN
          RNA_NNP transcript_NN ._. We_PRP therefore_RB incorporated_VBD each_DT of_IN these_DT
          modified_VBN nucleotides_NNS into_IN a_DT unique_JJ bacterial_JJ transcript_NN ,_,
          generated_VBN by_IN run_NN off_IN transcription_NN from_IN a_DT plasmid_NN into_IN
          which_WDT the_DT gene_NN was_VBD cloned_VBN ._. When_WRB this_DT transcript_NN was_VBD
          digested_VBN and_CC applied_VBN to_TO the_DT HPLC_NNP ,_, we_PRP found_VBD similar_JJ
          results_NNS as_IN seen_VBN with_IN the_DT complex_JJ cRNA_NN (_( data_NNS not_RB shown_VBN )_) ._.
          We_PRP conclude_VBP that_IN these_DT modified_VBN nucleotides_NNS are_VBP
          incorporated_VBN during_IN the_DT IVT_NNP reaction_NN at_IN ratios_NNS which_WDT are_VBP
          reflective_JJ of_IN the_DT input_NN ratio_NN to_TO the_DT unmodified_JJ
          counterpart_NN ._.
          Because_IN the_DT sensitivity_NN and_CC reproducibility_NN of_IN
          microarrays_NNS depends_VBZ on_IN the_DT specific_JJ activity_NN of_IN target_NN
          cRNA_NN ,_, we_PRP also_RB wanted_VBD to_TO determine_VB if_IN adding_VBG modified_VBN NTPs_NNP
          to_TO the_DT IVT_NNP changed_VBD the_DT incorporation_NN rate_NN of_IN
          biotin-_NN 11_CD -_: UTP_NNP ._. This_DT biotinylated_JJ nucleotide_NN is_VBZ used_VBN in_IN
          our_PRP$ biotin-streptavidin-_JJ Alexa_NNP 647_CD conjugate_NN detection_NN
          system_NN ._. We_PRP found_VBD that_IN the_DT level_NN of_IN biotinylated_JJ uridine_NN ,_,
          detected_VBD at_IN 294_CD nm_NN after_IN digestion_NN and_CC application_NN to_TO the_DT
          HPLC_NNP ,_, was_VBD unaffected_JJ by_IN the_DT presence_NN of_IN any_DT of_IN the_DT
          modified_VBN NTPs_NNP in_IN the_DT IVT_NNP reaction_NN cocktail_NN (_( data_NNS not_RB
          shown_VBN )_) ._. Moreover_RB ,_, analysis_NN of_IN individual_JJ transcripts_NNS ,_,
          which_WDT were_VBD enzymatically_RB digested_VBN into_IN mononucleosides_NNS ,_,
          showed_VBD equivalent_NN incorporation_NN rates_NNS of_IN biotin-_NN 11_CD -_: UTP_NNP
          for_IN both_DT control_NN samples_NNS and_CC target_NN samples_NNS containing_VBG
          modified_VBN ATP_NNP ._.
          Lastly_NNP ,_, we_PRP examined_VBD what_WP effect_NN ,_, if_IN any_DT ,_, incorporation_NN
          of_IN modified_VBN NTPs_NNP had_VBD on_IN the_DT length_NN of_IN the_DT amplified_VBN cRNA_NN ._.
          Transcript_NNP size_NN was_VBD determined_VBN by_IN running_VBG samples_NNS on_IN an_DT
          Agilent_NNP 2100_CD BioAnalyzer_NNP ._. No_DT difference_NN was_VBD observed_VBN for_IN
          either_DT individual_JJ transcripts_NNS or_CC complex_JJ samples_NNS in_IN
          modified_VBN versus_CC unmodified_JJ ATP_NNP samples_NNS (_( data_NNS not_RB
          shown_VBN )_) ._.
        
        
          Effect_NN of_IN modified_VBN nucleotides_NNS on_IN hybridization_NN
          signals_NNS and_CC specificity_NN
          We_PRP next_RB determined_VBD the_DT effect_NN of_IN these_DT modified_VBN NTPs_NNP
          on_IN hybridization_NN intensities_NNS ._. After_IN hybridization_NN ,_,
          scatter_NN plots_NNS of_IN hybridization_NN intensities_NNS were_VBD generated_VBN
          comparing_VBG those_DT intensities_NNS generated_VBN from_IN unmodified_JJ
          cRNA_NN (_( control_NN )_) to_TO either_CC the_DT duplicate_JJ control_NN
          hybridization_NN or_CC to_TO intensities_NNS generated_VBN from_IN cRNA_NN where_WRB
          one_CD of_IN the_DT modified_VBN NTPs_NNP was_VBD incorporated_VBN ._. The_DT comparison_NN
          of_IN control_NN versus_CC control_NN (_( Figure_NN 2_CD A_DT )_) illustrates_VBZ that_IN ,_,
          if_IN hybridization_NN intensities_NNS are_VBP equal_JJ in_IN the_DT two_CD
          conditions_NNS ,_, the_DT points_NNS should_MD lie_VB on_IN the_DT diagonal_NN ._.
          Complete_JJ substitution_NN of_IN unmodified_JJ ATP_NNP with_IN DAP_NNP (_( Figure_NN
          2_CD B_NNP )_) produced_VBN greater_JJR increases_NNS overall_JJ in_IN individual_JJ
          probe_NN signals_NNS than_IN the_DT target_NN sample_NN containing_VBG a_DT 1_CD :_: 1_CD
          ratio_NN of_IN DAP_NNP to_TO unmodified_JJ ATP_NNP (_( Figure_NN 2_CD C_NNP )_) ,_, as_IN would_MD be_VB
          expected_VBN if_IN DAP_NNP incorporation_NN increased_VBD the_DT DNA_NNP :_: RNA_NNP
          hybrid_JJ duplex_NN stability_NN ._. A_DT quantitative_JJ estimation_NN of_IN
          assay_NN performance_NN increase_NN can_MD be_VB derived_VBN from_IN the_DT median_JJ
          probe_NN signal_NN on_IN each_DT microarray_NN ._. Although_IN Figure_NN 2_CD Band_NNP
          2_CD Cshow_NNP that_IN increases_NNS in_IN signal_NN intensity_NN are_VBP not_RB linear_JJ
          for_IN all_DT probe_NN sequences_NNS ,_, median_JJ slide_NN intensity_NN across_IN
          sets_NNS of_IN duplicate_VB hybridizations_NNS for_IN two_CD different_JJ
          tissues_NNS (_( human_JJ embryonic_JJ kidney_NN and_CC Burkitt_NNP 's_POS lymphoma_NN )_)
          increased_VBD an_DT average_NN of_IN 40_CD %_NN +_NN /_NN -_: 7_CD %_NN and_CC 99_CD %_NN +_NN /_NN -_: 6_CD %_NN for_IN the_DT
          1_CD :_: 1_CD DAP_NNP :_: A_DT and_CC all_DT DAP_NNP conditions_NNS ,_, respectively_RB ,_, over_IN the_DT
          unmodified_JJ control_NN sample_NN ._. However_RB ,_, Figure_NN 2_CD Balso_NNP shows_VBZ
          that_IN full_JJ substitution_NN of_IN adenosine_NN by_IN DAP_NNP reduced_VBD the_DT
          hybridization_NN signals_NNS for_IN many_JJ of_IN the_DT probes_NNS ,_, generating_VBG
          a_DT bowing_VBG towards_IN the_DT unmodified_JJ control_NN condition_NN and_CC
          suggesting_VBG a_DT duplex_NN destabilizing_JJ effect_NN of_IN complete_JJ DAP_NNP
          substitution_NN in_IN certain_JJ sequence_NN contexts_NNS [_NN 11_CD 23_CD ]_NN ._. On_IN
          a_DT global_JJ scale_NN ,_, such_JJ a_DT high_JJ incidence_NN of_IN probes_NNS with_IN
          reduced_VBN hybridization_NN signals_NNS may_MD limit_VB the_DT usefulness_NN of_IN
          the_DT complete_JJ DAP_NNP substitution_NN ._. Of_IN particular_JJ interest_NN is_VBZ
          the_DT observation_NN that_IN the_DT number_NN of_IN probes_NNS which_WDT have_VBP
          increased_VBN signal_NN and_CC the_DT degree_NN to_TO which_WDT their_PRP$ signals_NNS
          are_VBP increased_VBN are_VBP highest_JJS at_IN the_DT lower_JJR end_NN of_IN the_DT signal_NN
          range_NN ._. In_IN contrast_NN ,_, both_DT of_IN the_DT modified_VBN pyrimidine_NN
          triphosphates_NNS (_( MeC_NNP and_CC MeU_NNP )_) tested_VBN resulted_VBD in_IN a_DT decrease_NN
          in_IN overall_JJ signal_NN intensities_NNS for_IN nearly_RB all_DT of_IN the_DT
          probes_NNS tested_VBN when_WRB compared_VBN against_IN unmodified_JJ control_NN
          samples_NNS (_( Figures_NNS 2_CD D_NNP &_CC 2_CD E_NNP )_) ._. However_RB ,_, data_NNS points_NNS on_IN the_DT
          right_NN of_IN the_DT diagonal_NN in_IN figures_NNS 2_CD Dand_NNP 2_CD Ealso_NNP show_NN that_IN
          for_IN a_DT fractional_JJ set_NN of_IN target-probe_JJ pairs_NNS ,_, substitution_NN
          with_IN MeC_NNP and_CC MeU_NNP increased_VBD hybridization_NN signal_NN relative_JJ
          to_TO the_DT unmodified_JJ control_NN ._. Those_DT probes_NNS whose_WP$ signal_NN
          intensities_NNS were_VBD increased_VBN at_IN least_JJS two-fold_JJ are_VBP
          summarized_VBD in_IN Table_NNP 1_CD ._. As_IN Table_NNP 1_CD shows_NNS ,_, for_IN a_DT number_NN of_IN
          transcripts_NNS substitution_NN with_IN MeC_NNP or_CC MeU_NNP may_MD potentially_RB
          augment_VB hybridization_NN signals_NNS more_RBR so_RB than_IN even_RB DAP_NNP ._. This_DT
          may_MD prove_VB useful_JJ for_IN target_NN samples_NNS containing_VBG very_RB low_JJ
          concentrations_NNS of_IN these_DT particular_JJ transcripts_NNS ._.
          Nevertheless_RB ,_, because_IN our_PRP$ goal_NN was_VBD to_TO utilize_VB
          modifications_NNS that_WDT would_MD increase_VB hybridization_NN signals_NNS
          for_IN the_DT vast_JJ majority_NN of_IN target-probe_JJ duplexes_NNS ,_, we_PRP
          subsequently_RB focused_VBD our_PRP$ efforts_NNS on_IN the_DT samples_NNS
          containing_VBG DAP_NNP ._.
          We_PRP next_RB determined_VBN whether_IN the_DT increases_NNS in_IN signal_NN
          intensity_NN observed_VBD with_IN DAP_NNP substitution_NN were_VBD similar_JJ in_IN
          magnitude_NN to_TO those_DT observed_VBD when_WRB the_DT hybridization_NN time_NN
          is_VBZ increased_VBN ._. We_PRP therefore_RB hybridized_JJ two_CD micrograms_NNS of_IN
          cRNA_NN with_IN no_DT modifications_NNS or_CC two_CD micrograms_NNS with_IN DAP_NNP at_IN
          a_DT 1_CD :_: 1_CD molar_NN ratio_NN to_TO adenosine_NN for_IN 18_CD hours_NNS and_CC
          hybridized_JJ two_CD micrograms_NNS of_IN cRNA_NN with_IN no_DT modifications_NNS
          for_IN 42_CD hours_NNS ._. We_PRP generated_VBD two_CD scatterplot_NN and_CC overplayed_JJ
          these_DT scatterplot_NN on_IN each_DT other_JJ (_( Figure_NN 3_CD A_DT )_) ._. The_DT first_JJ
          scatterplot_NN compares_VBZ the_DT intensities_NNS of_IN the_DT 18_CD hour_NN
          control_NN with_IN those_DT of_IN the_DT 42_CD hour_NN control_NN (_( orange_NN
          signals_NNS )_) ._. The_DT second_JJ scatterplot_NN compares_VBZ the_DT intensities_NNS
          of_IN the_DT 18_CD hour_NN control_NN with_IN those_DT of_IN the_DT DAP-modified_NNP
          cRNA_NN (_( blue_JJ signals_NNS )_) ._. The_DT longer_JJR hybridization_NN time_NN
          increases_VBZ the_DT median_JJ signal_NN intensity_NN by_IN 47_CD %_NN +_NN /_NN -_: 2_CD %_NN ._. The_DT
          increase_NN is_VBZ more_RBR pronounced_JJ for_IN the_DT medium_NN and_CC high_JJ
          signals_NNS ._. As_IN shown_VBN before_RB ,_, the_DT DAP-modified_NNP cRNA_NN generated_VBD
          hybridization_NN signals_NNS which_WDT were_VBD also_RB increased_VBN relative_JJ
          to_TO the_DT 18_CD hour_NN control_NN hybridization_NN ._. However_RB ,_, the_DT
          increase_NN seemed_VBD more_RBR pronounced_JJ for_IN the_DT low_NN and_CC medium_NN
          signals_NNS ._. We_PRP conclude_VBP that_IN both_DT DAP_NNP modification_NN and_CC an_DT
          increased_VBN hybridization_NN time_NN can_MD affect_VB the_DT hybridization_NN
          reaction_NN but_CC in_IN very_RB different_JJ ways_NNS ._.
          Because_IN of_IN the_DT differential_NN effects_NNS of_IN increased_VBN
          hybridization_NN time_NN and_CC DAP_NNP substitution_NN on_IN low_JJ and_CC high_JJ
          expressers_NNS ,_, we_PRP wanted_VBD determine_VB whether_IN the_DT increases_NNS
          seen_VBN of_IN using_VBG both_DT DAP_NNP modification_NN and_CC an_DT extended_VBN
          hybridization_NN time_NN could_MD be_VB additive_JJ ._. We_PRP therefore_RB
          hybridized_JJ unmodified_JJ (_( control_NN )_) cRNA_NN for_IN 18_CD hours_NNS and_CC a_DT
          DAP-modified_NNP cRNA_NN for_IN 42_CD hours_NNS (_( Figure_NN 3_CD B_NNP )_) ._. The_DT median_JJ
          slide_NN intensity_NN increased_VBD by_IN 110_CD %_NN +_NN /_NN -_: 17_CD %_NN ,_, which_WDT is_VBZ
          approximately_RB double_VB the_DT increase_NN seen_VBN with_IN either_DT the_DT
          1_CD :_: 1_CD DAP_NNP :_: A_DT or_CC the_DT longer_JJR hybridization_NN time_NN by_IN themselves_PRP ._.
          When_WRB all_DT of_IN the_DT approximately_RB 9_CD ,_, 000_CD probes_NNS are_VBP divided_VBN
          into_IN three_CD equally_RB sized_VBD bins_NNS representing_VBG low_JJ ,_, medium_NN ,_,
          and_CC high_JJ expressers_NNS according_VBG to_TO their_PRP$ respective_JJ signal_NN
          intensities_NNS ,_, the_DT effects_NNS of_IN increased_VBN hybridization_NN time_NN
          and_CC DAP_NNP become_VBP very_RB evident_JJ (_( Figure_NN 3_CD C_NNP )_) ._. Figure_NN 3_CD Cshows_NNP
          that_IN the_DT relative_JJ increases_NNS in_IN signal_NN intensities_NNS due_JJ to_TO
          increased_VB hybridization_NN time_NN are_VBP biased_VBN towards_IN the_DT
          medium_NN and_CC high_JJ expressers_NNS ,_, with_IN signals_NNS increasing_VBG an_DT
          average_NN of_IN 48_CD %_NN and_CC 84_CD %_NN ,_, respectively_RB ,_, whereas_IN increases_NNS
          due_JJ to_TO DAP_NNP substitution_NN are_VBP more_RBR pronounced_JJ for_IN low_NN and_CC
          medium_NN expressers_NNS (_( 57_CD %_NN and_CC 81_CD %_NN increase_NN ,_, respectively_RB )_) ._.
          Together_RB ,_, the_DT two_CD modifications_NNS of_IN increased_VBN
          hybridization_NN time_NN and_CC DAP_NNP substitution_NN can_MD be_VB used_VBN in_IN
          concert_NN to_TO amplify_VB signal_NN intensities_NNS for_IN the_DT entire_JJ
          range_NN of_IN probe_NN signals_NNS ,_, and_CC as_IN figure_NN 3_CD Cindicates_NNP ,_, these_DT
          boosts_VBZ in_IN signals_NNS are_VBP approximately_RB additive_JJ for_IN the_DT 42_CD
          hour_NN ,_, DAP-containing_NNP samples_NNS ._.
          We_PRP next_RB determined_VBD the_DT effect_NN of_IN modified_VBN NTPs_NNP on_IN
          hybridization_NN specificity_NN (_( the_DT ability_NN to_TO distinguish_VB
          sequences_NNS up_IN to_TO a_DT certain_JJ homology_NN )_) ._. We_PRP addressed_VBD this_DT
          issue_NN by_IN designing_VBG probes_NNS which_WDT had_VBD one_CD to_TO four_CD adjacent_JJ ,_,
          centrally_RB located_VBN mismatches_NNS and_CC comparing_VBG hybridization_NN
          signals_NNS generated_VBN from_IN these_DT mismatched_JJ probes_NNS to_TO signals_NNS
          generated_VBN from_IN their_PRP$ corresponding_JJ perfect_JJ matches_NNS ._. In_IN
          the_DT control_NN situation_NN (_( hybridization_NN of_IN unmodified_JJ cRNA_NN )_) ,_,
          the_DT hybridization_NN intensity_NN decreased_VBD as_IN the_DT number_NN of_IN
          mismatches_NNS increased_VBN ,_, with_IN two_CD mismatches_NNS generally_RB
          destabilizing_VBG the_DT duplex_NN sufficiently_RB to_TO reduce_VB the_DT
          hybridization_NN signal_NN to_TO 0_CD %_NN of_IN the_DT parent_NN signal_NN ._. There_EX
          was_VBD one_CD exception_NN (_( Figure_NN 4_CD C_NNP )_) where_WRB ,_, even_RB in_IN the_DT presence_NN
          of_IN four_CD mismatches_NNS ,_, the_DT signal_NN was_VBD not_RB reduced_VBN below_IN 60_CD %_NN
          of_IN the_DT parent_NN signal_NN ._. This_DT signal_NN was_VBD low_JJ in_IN the_DT perfect_JJ
          match_NN and_CC ,_, therefore_RB ,_, this_DT situation_NN most_RBS likely_JJ reflects_VBZ
          a_DT lowering_VBG to_TO the_DT noise_NN levels_NNS ._. In_IN fact_NN ,_, the_DT signal_NN was_VBD
          lowered_VBN to_TO below_IN threshold_NN levels_NNS in_IN the_DT presence_NN of_IN
          mismatches_NNS ._. When_WRB equimolar_NN ratios_NNS of_IN DAP_NNP and_CC unmodified_JJ
          ATP_NNP were_VBD incorporated_VBN into_IN the_DT cRNA_NN target_NN (_( 1_CD :_: 1_CD DAP_NNP :_: A_DT )_) ,_,
          specificity_NN was_VBD not_RB significantly_RB affected_VBN in_IN two_CD of_IN the_DT
          four_CD probe_NN sequences_NNS (_( Figure_NN 4_CD Aand_NNP 4_CD B_NNP )_) ._. However_RB ,_, in_IN one_CD
          probe_NN sequence_NN (_( Figure_NN 4_CD C_NNP )_) ,_, specificity_NN was_VBD enhanced_VBN ._. For_IN
          this_DT test_NN probe_NN ,_, the_DT unmodified_JJ sample_NN produced_VBN unusually_RB
          high_JJ signals_NNS for_IN base_NN mismatches_NNS ._. Nevertheless_RB ,_, other_JJ
          groups_NNS have_VBP seen_VBN similar_JJ improvements_NNS in_IN mismatch_NN
          discrimination_NN with_IN diaminopurine-containing_JJ oligo_NN mers_NNS
          for_IN different_JJ applications_NNS [_NN 13_CD ]_NN ._. A_DT fourth_JJ probe_NN
          sequence_NN demonstrated_VBD a_DT smaller_JJR destabilizing_JJ effect_NN of_IN a_DT
          single_JJ mismatch_NN with_IN the_DT partially_RB modified_VBN cRNA_NN compared_VBN
          to_TO the_DT control_NN (_( Figure_NN 4_CD D_NNP )_) ._. In_IN this_DT sequence_NN ,_, the_DT
          hybridization_NN was_VBD reduced_VBN to_TO the_DT same_JJ extent_NN with_IN three_CD
          mismatches_NNS using_VBG either_CC the_DT control_NN or_CC partially_RB modified_VBN
          cRNA_NN ._. Full_NNP substitution_NN of_IN adenosine_NN by_IN DAP_NNP showed_VBD varied_VBN
          effects_NNS on_IN specificity_NN in_IN the_DT four_CD different_JJ probe_NN
          sequences_NNS ._. In_IN two_CD of_IN the_DT probe_NN sequences_NNS ,_, the_DT fully_RB
          modified_VBN cRNA_NN behaved_VBD similarly_RB to_TO the_DT control_NN cRNA_NN
          (_( Figures_NNS 4_CD Aand_NNP 4_CD B_NNP )_) ._. In_IN a_DT third_JJ probe_NN sequence_NN ,_, the_DT
          specificity_NN improved_VBN for_IN the_DT fully_RB modified_VBN cRNA_NN ,_, as_IN it_PRP
          did_VBD for_IN the_DT partially_RB modified_VBN cRNA_NN (_( Figure_NN 4_CD C_NNP )_) ._. The_DT
          improvement_NN in_IN specificity_NN for_IN this_DT probe_NN depended_VBD on_IN the_DT
          extent_NN of_IN DAP_NNP modification_NN ._. In_IN a_DT fourth_JJ probe_NN sequence_NN ,_,
          the_DT fully_RB modified_VBN cRNA_NN showed_VBD a_DT dramatic_JJ decrease_NN in_IN
          specificity_NN with_IN one-_NN or_CC two-base_JJ mismatches_NNS ,_, although_IN
          three_CD mismatches_NNS reduced_VBD the_DT hybridization_NN intensity_NN to_TO
          ~_NN 10_CD %_NN of_IN that_DT of_IN the_DT perfect_JJ match_NN ._. The_DT loss_NN in_IN
          specificity_NN for_IN this_DT probe_NN sequence_NN also_RB depended_VBD on_IN the_DT
          extent_NN of_IN DAP_NNP modification_NN ,_, with_IN one_CD ,_, two_CD ,_, or_CC three_CD
          mismatches_NNS required_VBN to_TO reduce_VB the_DT hybridization_NN intensity_NN
          to_TO ~_NN 10_CD %_NN for_IN the_DT control_NN ,_, partially_RB modified_VBN ,_, and_CC fully_RB
          modified_VBN ,_, respectively_RB ,_, cRNA_NN ._. A_DT fifth_JJ test_NN probe_NN showed_VBD
          hybridization_NN signal_NN intensity_NN below_IN the_DT negative_JJ control_NN
          threshold_NN in_IN both_DT the_DT control_NN and_CC modified_VBN ATP_NNP samples_NNS ,_,
          suggesting_VBG either_CC an_DT absence_NN of_IN the_DT transcript_NN from_IN the_DT
          target_NN sample_NN or_CC abundance_NN too_RB low_JJ to_TO quantify_VB (_( data_NNS not_RB
          shown_VBN )_) ._. Repeat_NN experiments_NNS with_IN cRNA_NN containing_VBG modified_VBN
          ATP_NNP supported_VBD the_DT general_JJ specificity_NN trend_NN :_: unmodified_JJ
          ATP_NNP >_NN 1_CD :_: 1_CD DAP_NNP :_: A_DT >_NN all_DT DAP_NNP (_( data_NNS not_RB shown_VBN )_) ._.
          Attempts_NNS to_TO increase_VB specificity_NN in_IN the_DT all_DT DAP_NNP condition_NN
          by_IN raising_VBG the_DT temperature_NN during_IN hybridization_NN from_IN 37_CD °_NN C_NNP
          to_TO 42_CD °_NN C_NNP or_CC 47_CD °_NN C_NNP were_VBD unsuccessful_JJ (_( data_NNS not_RB shown_VBN )_) ._.
          Others_NNS have_VBP been_VBN able_JJ to_TO distinguish_VB sequences_NNS of_IN up_IN to_TO
          90_CD %_NN homology_NN [_NN 6_CD ]_NN using_VBG the_DT same_JJ platform_NN (_( 3_CD -_: base_NN
          mismatch_NN /_NN 30_CD -_: mer_NN oligonucleotide_NN signal_NN near_IN or_CC below_IN
          negative_JJ control_NN threshold_NN )_) ,_, and_CC we_PRP support_VBP their_PRP$
          findings_NNS here_RB with_IN the_DT control_NN and_CC 1_CD :_: 1_CD DAP_NNP :_: A_DT condition_NN ._.
          The_DT fully_RB MeC-substituted_NNP cRNA_NN targets_NNS were_VBD examined_VBN with_IN
          respect_NN to_TO specificity_NN in_IN two_CD test_NN sequences_NNS (_( Figures_NNS
          4_CD Band_NNP 4_CD D_NNP )_) ._. In_IN one_CD test_NN sequence_NN (_( Figure_NNP B_NNP )_) ,_, the_DT fully_RB
          MeC-substituted_NNP cRNA_NN targets_NNS behaved_VBD nearly_RB identically_RB
          to_TO the_DT partially_RB DAP-substituted_NNP targets_NNS ._. In_IN the_DT other_JJ
          test_NN sequence_NN (_( Figure_NN 4_CD D_NNP )_) ,_, the_DT MeC-substituted_NNP cRNA_NN
          behaved_VBD nearly_RB identically_RB to_TO the_DT unmodified_JJ cRNA_NN target_NN
          and_CC showed_VBD better_JJR specificity_NN than_IN that_DT of_IN the_DT partially_RB
          DAP-substituted_NNP cRNA_NN target_NN with_IN respect_NN to_TO the_DT effect_NN of_IN
          one_CD mismatch_NN ._. We_PRP conclude_VBP that_IN the_DT specificity_NN of_IN fully_RB
          MeC-substituted_NNP cRNA_NN and_CC partially_RB DAP-substituted_NNP cRNA_NN
          targets_NNS are_VBP ,_, for_IN the_DT most_JJS part_NN ,_, equivalent_NN and_CC
          essentially_RB no_DT loss_NN in_IN specificity_NN (_( as_IN determined_VBN by_IN the_DT
          effect_NN of_IN two_CD mismatches_NNS )_) is_VBZ observed_VBN with_IN these_DT modified_VBN
          targets_NNS ._.
          An_DT additional_JJ metric_NN of_IN specificity_NN on_IN the_DT Codelink_NNP
          bioarrays_NNS is_VBZ the_DT use_NN of_IN 54_CD negative_JJ control_NN bacterial_JJ
          probes_NNS spotted_VBD in_IN 4_CD X_NNP redundancy_NN ,_, which_WDT were_VBD designed_VBN and_CC
          empirically_RB shown_VBN not_RB to_TO cross_VB hybridize_NN to_TO human_JJ
          transcripts_NNS [_NN 6_CD ]_NN ._. While_IN the_DT all_DT DAP_NNP condition_NN resulted_VBD
          in_IN an_DT increase_NN in_IN the_DT hybridization_NN intensity_NN for_IN three_CD
          of_IN the_DT negative_JJ control_NN probes_NNS ,_, the_DT 1_CD :_: 1_CD DAP_NNP :_: A_DT condition_NN
          produced_VBN lower_JJR background_NN signals_NNS similar_JJ to_TO those_DT of_IN the_DT
          unmodified_JJ control_NN (_( data_NNS not_RB shown_VBN )_) ._. Thus_RB ,_, increases_NNS in_IN
          hybridization_NN signal_NN intensities_NNS in_IN the_DT 1_CD :_: 1_CD DAP_NNP :_: A_DT
          condition_NN are_VBP attributable_JJ to_TO specific_JJ modified_VBN cRNA_NN
          target_NN /_NN DNA_NNP probe_NN interactions_NNS ._. We_PRP conclude_VBP that_IN partial_JJ
          substitution_NN of_IN adenosine_NN with_IN DAP_NNP does_VBZ not_RB significantly_RB
          compromise_VB specificity_NN and_CC was_VBD ,_, therefore_RB ,_, investigated_VBD
          further_RB ._.
        
        
          Effect_NN of_IN DAP_NNP incorporation_NN on_IN differential_NN
          expression_NN ratios_NNS
          Ultimately_RB ,_, the_DT goal_NN of_IN any_DT global_JJ expression_NN
          profiling_VBG system_NN measuring_VBG relative_JJ transcript_NN abundance_NN
          is_VBZ to_TO accurately_RB and_CC reproducibly_RB determine_VB the_DT changes_NNS
          in_IN expression_NN levels_NNS between_IN different_JJ target_NN samples_NNS ._. We_PRP
          therefore_RB determined_VBD if_IN the_DT increases_NNS in_IN signal_NN intensity_NN
          caused_VBN by_IN DAP_NNP incorporation_NN had_VBD an_DT effect_NN on_IN differential_NN
          ratio_NN calls_NNS ._. Kidney_NNP and_CC lymphoma_NN cRNA_NN samples_NNS containing_VBG
          either_CC no_DT modified_VBN NTPs_NNP or_CC 1_CD :_: 1_CD DAP_NNP :_: A_DT were_VBD hybridized_JJ in_IN
          duplicate_VB to_TO Human_NNP Uniset_NNP I_PRP arrays_NNS ;_: average_JJ kidney_NN to_TO
          lymphoma_NN ratios_NNS were_VBD calculated_VBN and_CC plotted_VBD (_( Figure_NN 5_LS )_)
          after_IN removing_VBG signal_NN outliers_NNS defined_VBN as_IN a_DT two-fold_JJ
          difference_NN between_IN replicates_NNS ._. Differential_NNP expression_NN
          ratios_NNS demonstrate_VBP very_RB good_JJ correlation_NN between_IN the_DT
          unmodified_JJ control_NN sample_NN and_CC the_DT 1_CD :_: 1_CD DAP_NNP :_: A_DT sample_NN (_( r_LS =_SYM
          0_CD ._. 95_CD )_) on_IN the_DT Human_NNP Uniset_NNP I_PRP microarray_NN ._.
          In_IN addition_NN to_TO investigating_VBG the_DT correlation_NN of_IN the_DT
          differential_NN expression_NN ratios_NNS generated_VBN from_IN modified_VBN
          and_CC unmodified_JJ targets_NNS ,_, we_PRP determined_VBD whether_IN DAP_NNP
          incorporation_NN affected_VBD the_DT variability_NN of_IN the_DT ratio_NN
          calls_NNS ._. One_CD method_NN to_TO measure_VB microarray_NN reproducibility_NN
          is_VBZ by_IN calculating_VBG the_DT coefficients_NNS of_IN variation_NN (_( CVs_NNP )_) for_IN
          each_DT replicate_VB probe_NN across_IN arrays_NNS ._. Likewise_RB ,_, CVs_NNP can_MD
          also_RB be_VB calculated_VBN for_IN multiple_JJ ratio_NN calculations_NNS across_IN
          different_JJ tissue_NN samples_NNS ._. Figure_NN 6_CD shows_VBZ a_DT plot_NN of_IN the_DT CVs_NNP
          of_IN the_DT ratios_NNS as_IN a_DT function_NN of_IN the_DT mean_NN ratios_NNS for_IN all_DT of_IN
          the_DT data_NNS points_NNS ,_, 
          regardless_RB of_IN the_DT intensity_NN level_NN of_IN
          the_DT probe_NN ._. Consistent_NNP with_IN earlier_JJR findings_NNS [_NN 6_CD ]_NN ,_,
          the_DT majority_NN of_IN the_DT CVs_NNP in_IN the_DT of_IN the_DT kidney_NN to_TO lymphoma_NN
          ratios_NNS are_VBP below_IN 30_CD %_NN ,_, with_IN an_DT average_NN of_IN 13_CD ._. 2_LS %_NN ,_, and_CC the_DT
          variability_NN increases_NNS as_IN the_DT ratio_NN approaches_NNS unity_NN for_IN
          the_DT unmodified_JJ targets_NNS (_( Figure_NN 6_CD A_DT )_) ._. Figure_NN 6_CD Bshows_NNP that_IN
          the_DT 1_CD :_: 1_CD DAP_NNP :_: A_DT condition_NN produces_VBZ ratios_NNS with_IN similar_JJ
          overall_JJ variability_NN (_( average_JJ CV_NNP of_IN 12_CD ._. 4_LS %_NN )_) compared_VBN to_TO the_DT
          unmodified_JJ control_NN targets_NNS ._. When_WRB the_DT CVs_NNP in_IN the_DT ratios_NNS
          generated_VBD using_VBG either_CC the_DT control_NN or_CC partially_RB modified_VBN
          cRNA_NN are_VBP binned_JJ according_VBG to_TO the_DT magnitude_NN of_IN the_DT CV_NNP ,_, the_DT
          partially_RB modified_VBN cRNA_NN generates_VBZ more_JJR CVs_NNP in_IN the_DT less_JJR
          than_IN 20_CD %_NN bins_NNS (_( Figure_NN 6_CD C_NNP )_) ._. These_DT data_NNS demonstrate_VBP that_IN
          the_DT low_JJ variability_NN in_IN ratio_NN calls_VBZ that_IN we_PRP are_VBP able_JJ to_TO
          routinely_RB obtain_VB [_NN 6_CD ]_NN are_VBP maintained_VBN during_IN DAP_NNP
          incorporation_NN ._. However_RB ,_, a_DT closer_JJR inspection_NN of_IN the_DT ratios_NNS
          in_IN Figures_NNS 6_CD Aand_NNP 6_CD Breveals_NNP that_IN a_DT possible_JJ caveat_NN of_IN DAP_NNP
          use_NN is_VBZ a_DT slight_JJ compression_NN of_IN ratios_NNS along_IN the_DT entire_JJ
          range_NN of_IN calls_NNS ._. This_DT compression_NN is_VBZ also_RB observed_VBN when_WRB
          the_DT observed_VBN ratio_NN is_VBZ binned_JJ according_VBG to_TO the_DT magnitude_NN
          of_IN the_DT fold_VB change_NN (_( Figure_NN 6_CD D_NNP )_) ._. The_DT partially_RB modified_VBN
          cRNA_NN generates_VBZ more_JJR ratios_NNS in_IN the_DT one_CD to_TO 1_CD ._. 5_CD fold_VB change_NN
          bin_NN and_CC fewer_JJR ratio_NN changes_NNS in_IN the_DT other_JJ bins_NNS ._. This_DT
          compression_NN is_VBZ not_RB significant_JJ but_CC also_RB manifests_NNS itself_PRP
          in_IN the_DT slope_NN of_IN the_DT correlation_NN line_NN in_IN Figure_NN 5_CD ._. The_DT
          slope_NN of_IN this_DT line_NN was_VBD found_VBN to_TO be_VB greater_JJR than_IN
          unity_NN ._.
          The_DT differential_NN expression_NN ratios_NNS calculated_VBN when_WRB
          using_VBG DAP_NNP (_( Figures_NNS 5_CD and_CC 6_CD )_) suggest_VBP that_DT incorporation_NN of_IN
          DAP_NNP has_VBZ little_JJ effect_NN on_IN correlation_NN and_CC reproducibility_NN
          of_IN ratio_NN calls_VBZ between_IN tissues_NNS ._. However_RB ,_, the_DT ability_NN to_TO
          accurately_RB discriminate_JJ between_IN signals_NNS due_JJ to_TO true_JJ
          hybridization_NN events_NNS and_CC what_WP may_MD be_VB considered_VBN
          background_NN noise_NN is_VBZ paramount_JJ to_TO making_VBG accurate_JJ
          differential_NN assessments_NNS ._. A_DT lower_JJR limit_NN of_IN detection_NN was_VBD
          previously_RB defined_VBN using_VBG our_PRP$ platform_NN by_IN developing_VBG a_DT
          negative_JJ control_NN threshold_NN in_IN order_NN to_TO assign_VB a_DT
          confidence_NN level_NN to_TO such_JJ signal_NN or_CC noise_NN queries_NNS [_NN 6_CD ]_NN ._.
          Briefly_NNP ,_, this_DT threshold_NN was_VBD determined_VBN by_IN taking_VBG the_DT mean_JJ
          signal_NN of_IN bacterial_JJ negative_JJ control_NN probes_NNS mentioned_VBN
          above_IN (_( minus_CC a_DT 10_CD %_NN trim_VB to_TO account_VB for_IN weak_JJ cross_NN
          hybridization_NN of_IN high_JJ expressers_NNS or_CC for_IN true_JJ
          hybridization_NN to_TO sequences_NNS not_RB in_IN the_DT database_NN )_) and_CC
          adding_VBG three_CD standard_JJ deviations_NNS (_( 99_CD ._. 7_CD %_NN confidence_NN )_) ._.
          Using_VBG only_RB probes_NNS that_WDT were_VBD at_IN or_CC above_IN the_DT negative_JJ
          control_NN threshold_NN in_IN both_DT tissues_NNS ,_, we_PRP observed_VBD a_DT
          significantly_RB greater_JJR number_NN of_IN probes_NNS in_IN the_DT 1_CD :_: 1_CD DAP_NNP :_: A_DT
          sample_NN for_IN which_WDT we_PRP could_MD confidently_RB assign_VB a_DT ratio_NN
          (_( Figure_NN 7_CD )_) ._. As_IN Figure_NN 7_CD shows_NNS ,_, samples_NNS containing_VBG DAP_NNP
          generated_VBD over_IN 400_CD more_RBR above-threshold_JJ ratios_NNS than_IN the_DT
          control_NN samples_NNS containing_VBG only_RB unmodified_JJ NTPs_NNP ._. Most_JJS of_IN
          these_DT ratios_NNS identified_VBN only_RB in_IN the_DT 1_CD :_: 1_CD DAP_NNP :_: A_DT sample_NN were_VBD
          small_JJ in_IN magnitude_NN ,_, with_IN fold_VB changes_NNS between_IN 1_CD ._. 1_CD and_CC
          1_CD ._. 9_CD ._.
        
      
      
        Discussion_NNP
        
          The_DT effect_NN of_IN modified_VBN NTPs_NNP on_IN hybridization_NN
          intensities_NNS
          Two_CD important_JJ issues_NNS for_IN identifying_VBG differentially_RB
          expressed_VBD genes_NNS using_VBG DNA_NNP microarrays_NNS are_VBP 1_LS )_) methods_NNS to_TO
          increase_VB signal_NN intensity_NN and_CC 2_LS )_) the_DT ability_NN to_TO
          accurately_RB separate_JJ true_JJ hybridization_NN signals_NNS from_IN
          background_NN noise_NN at_IN the_DT low_JJ end_NN of_IN the_DT signal_NN dynamic_JJ
          range_NN ._. In_IN this_DT study_NN ,_, we_PRP utilized_JJ modified_VBN nucleoside_NN
          triphosphates_NNS with_IN the_DT aim_NN of_IN enhancing_VBG hybridization_NN
          signal_NN intensity_NN across_IN a_DT wide_JJ range_NN of_IN probe_NN sequences_NNS ._.
          Modified_NNP ribo-_NN and_CC deoxyribonucleoside_NN analogs_NNS have_VBP been_VBN
          used_VBN in_IN a_DT variety_NN of_IN applications_NNS [_NN 12_CD 13_CD 14_CD ]_NN ,_, but_CC
          their_PRP$ use_NN has_VBZ been_VBN limited_JJ in_IN the_DT field_NN of_IN microarrays_NNS [_NN
          23_CD ]_NN ._. We_PRP demonstrate_VBP that_IN 2_CD -_: aminoadenosine_NN or_CC
          2_CD ,_, 6_CD -_: diaminopurine_NN (_( DAP_NNP )_) ,_, an_DT analog_NN of_IN adenosine_NN ,_,
          significantly_RB increases_VBZ signal_VBP intensity_NN for_IN a_DT wide_JJ range_NN
          of_IN probe_NN sequences_NNS ,_, whereas_IN C-_NNP 5_CD methylated_JJ pyrimidine_NN
          analogs_NNS of_IN cytosine_NN and_CC uridine_NN decreased_VBD signal_NN
          intensities_NNS across_IN the_DT entire_JJ range_NN of_IN probe_NN sequences_NNS on_IN
          our_PRP$ platform_NN (_( Figure_NN 2_LS )_) ._.
          Although_IN incorporation_NN of_IN DAP_NNP did_VBD not_RB uniformly_RB
          increase_VB the_DT hybridization_NN stability_NN for_IN all_DT target-probe_JJ
          duplexes_NNS ,_, even_RB moderate_JJ incorporation_NN of_IN DAP_NNP (_( 1_CD :_: 1_CD DAP_NNP :_: A_DT )_)
          resulted_VBD in_IN signal_NN intensity_NN increases_NNS (_( up_IN to_TO 30_CD -_: fold_VB )_)
          for_IN the_DT majority_NN of_IN probes_NNS on_IN our_PRP$ platform_NN ._. More_RBR
          importantly_RB ,_, a_DT significant_JJ number_NN of_IN probes_NNS that_WDT went_VBD
          previously_RB undetected_JJ (_( i_NNP ._. e_SYM ._. ,_, below_IN a_DT negative_JJ control_NN
          threshold_NN ;_: [_NN 6_CD ]_NN )_) in_IN the_DT control_NN sample_NN exhibited_VBN signal_NN
          intensities_NNS above_IN this_DT threshold_NN in_IN DAP-modified_NNP samples_NNS ._.
          Utilization_NN of_IN such_JJ a_DT modification_NN may_MD prove_VB especially_RB
          valuable_JJ for_IN low_JJ abundant_JJ transcripts_NNS which_WDT may_MD be_VB
          difficult_JJ to_TO quantify_VB because_IN of_IN weak_JJ hybridization_NN
          kinetics_NNS ._. As_IN shown_VBN in_IN Figures_NNS 2_CD Band_NNP 2_CD C_NNP ,_, the_DT largest_JJS
          increases_NNS in_IN signal_NN intensities_NNS occurred_VBD for_IN low_NN and_CC
          medium_NN expressers_NNS relative_JJ to_TO the_DT unmodified_JJ control_NN
          sample_NN ._. It_PRP is_VBZ apparent_JJ that_IN the_DT effect_NN of_IN DAP_NNP depends_VBZ not_RB
          only_RB on_IN the_DT sequence_NN compositions_NNS of_IN target_NN and_CC probe_NN ,_,
          but_CC also_RB on_IN the_DT absolute_JJ abundance_NN of_IN specific_JJ
          transcripts_NNS in_IN the_DT target_NN sample_NN ._.
          It_PRP is_VBZ of_IN interest_NN to_TO note_VB that_IN the_DT results_NNS we_PRP report_VBP
          here_RB differ_VB from_IN those_DT obtained_VBN by_IN others_NNS [_NN 23_CD ]_NN ._. Those_DT
          studies_NNS reported_VBD increases_NNS in_IN signal_NN intensity_NN for_IN
          targets_NNS containing_VBG 5_CD -_: methyl_NN UTP_NNP while_IN completely_RB
          substituted_VBN targets_NNS containing_VBG DAP_NNP had_VBD the_DT opposite_JJ or_CC no_DT
          effect_NN ._. Although_IN we_PRP cannot_NN completely_RB account_NN for_IN the_DT
          disparity_NN of_IN the_DT results_NNS ,_, one_CD key_JJ difference_NN in_IN
          methodology_NN between_IN the_DT studies_NNS is_VBZ that_IN their_PRP$ group_NN was_VBD
          not_RB able_JJ to_TO normalize_VB concentrations_NNS for_IN modified_VBN and_CC
          unmodified_JJ ATP_NNP targets_NNS because_IN of_IN dramatic_JJ differences_NNS in_IN
          cRNA_NN yield_NN ._. Therefore_RB ,_, mass_NN input_NN of_IN cRNA_NN target_NN samples_NNS
          were_VBD much_RB greater_JJR for_IN unmodified_JJ samples_NNS compared_VBN to_TO the_DT
          DAP-containing_NNP samples_NNS ._. Because_IN the_DT sample_NN preparation_NN
          used_VBN in_IN this_DT protocol_NN is_VBZ highly_RB robust_JJ and_CC reproducible_JJ [_NN
          24_CD ]_NN ,_, we_PRP were_VBD able_JJ to_TO use_VB equivalent_NN mass_NN inputs_NNS of_IN all_DT
          modified_VBN and_CC unmodified_JJ targets_NNS during_IN hybridization_NN ,_,
          allowing_VBG us_PRP to_TO present_VB our_PRP$ results_NNS quantitatively_RB rather_RB
          than_IN qualitatively_RB ._. However_RB ,_, we_PRP agree_VBP that_IN complete_JJ
          substitution_NN of_IN DAP_NNP for_IN adenosine_NN may_MD cause_VB specificity_NN
          to_TO decline_VB in_IN certain_JJ sequence_NN contexts_NNS ,_, which_WDT may_MD limit_VB
          its_PRP$ usefulness_NN in_IN microarray_NN applications_NNS ._. However_RB ,_, we_PRP
          have_VBP found_VBN that_IN reducing_VBG the_DT proportion_NN of_IN DAP_NNP
          incorporated_VBD into_IN target_NN samples_NNS (_( e_SYM ._. g_SYM ._. ,_, incorporating_VBG a_DT
          1_CD :_: 1_CD ratio_NN of_IN DAP_NNP :_: adenosine_NN )_) is_VBZ one_CD approach_NN to_TO avoid_VB such_JJ
          decreases_NNS in_IN specificity_NN ._. Other_JJ factors_NNS that_WDT may_MD
          contribute_VB to_TO the_DT dissimilarity_NN of_IN the_DT results_NNS include_VBP
          differences_NNS in_IN probe_NN sequence_NN and_CC size_NN ,_, microarray_NN
          fabrication_NN /_NN chemistries_NNS ,_, labeling_VBG /_NN detection_NN methods_NNS ,_, and_CC
          the_DT vigorous_JJ mixing_VBG that_WDT is_VBZ employed_VBN in_IN our_PRP$ microarray_NN
          experiments_NNS ._. We_PRP have_VBP previously_RB shown_VBN the_DT dramatic_JJ impact_NN
          of_IN mixing_VBG on_IN hybridization_NN signal_NN intensities_NNS [_NN 6_CD ]_NN ._.
          Presumably_RB ,_, this_DT impact_NN is_VBZ due_JJ to_TO the_DT effect_NN of_IN three_CD
          dimensional_NN diffusion_NN of_IN the_DT target_NN molecules_NNS and_CC to_TO the_DT
          effect_NN on_IN how_WRB many_JJ probes_NNS reach_VBP equilibrium_NN in_IN the_DT
          hybridization_NN ._. It_PRP is_VBZ possible_JJ that_IN the_DT degree_NN of_IN mixing_VBG
          during_IN the_DT hybridization_NN can_MD affect_VB the_DT number_NN of_IN probes_NNS
          which_WDT show_VBP a_DT difference_NN in_IN intensity_NN with_IN substitution_NN of_IN
          DAP_NNP for_IN adenosine_NN as_RB well_RB as_IN the_DT magnitude_NN of_IN this_DT
          difference_NN ._. Given_VBN these_DT differences_NNS ,_, it_PRP is_VBZ not_RB surprising_JJ
          that_IN our_PRP$ results_NNS are_VBP not_RB in_IN line_NN with_IN those_DT previously_RB
          reported_VBN ._.
          The_DT results_NNS in_IN our_PRP$ study_NN are_VBP in_IN good_JJ agreement_NN with_IN
          previous_JJ reports_NNS which_WDT include_VBP a_DT wide_JJ variety_NN of_IN
          interaction_NN types_NNS ,_, including_VBG DNA_NNP :_: DNA_NNP ,_, DNA_NNP :_: RNA_NNP ,_, and_CC
          DNA_NNP :_: PNA_NNP interactions_NNS ._. [_NN 11_CD 12_CD 13_CD 25_CD ]_NN ._. These_DT studies_NNS
          have_VBP shown_VBN that_IN DAP_NNP substitution_NN in_IN oligonucleotide_NN
          probes_NNS can_MD increase_VB thermodynamic_JJ affinities_NNS as_IN reported_VBN
          directly_RB by_IN increases_NNS in_IN T_NN 
          m_NN and_CC indirectly_RB through_IN increases_NNS in_IN
          hybridization_NN intensities_NNS ._.
        
        
          Biophysical_NNP considerations_NNS in_IN using_VBG modified_VBN
          NTPs_NNP
          Modified_NNP nucleotides_NNS appear_VBP to_TO drive_VB the_DT equilibrium_NN
          (_( particularly_RB for_IN low_JJ copy_NN transcripts_NNS binding_JJ with_IN their_PRP$
          targets_NNS )_) towards_IN duplex_NN formation_NN ._. These_DT findings_NNS suggest_VBP
          that_IN DAP_NNP use_NN could_MD be_VB exploited_VBN in_IN RNA_NNP samples_NNS that_WDT are_VBP
          limited_JJ ,_, such_JJ as_IN tumor_NN biopsies_NNS ._. Based_VBN on_IN our_PRP$ experiments_NNS
          with_IN extended_VBN hybridization_NN times_NNS (_( Figure_NN 3_LS )_) ,_, use_NN of_IN DAP_NNP
          may_MD prove_VB to_TO be_VB a_DT useful_JJ alternative_NN to_TO increase_VB array_NN
          sensitivity_NN for_IN studies_NNS that_WDT are_VBP unable_JJ to_TO generate_VB
          enough_JJ target_NN to_TO hybridize_NN or_CC are_VBP unable_JJ to_TO increase_VB
          hybridization_NN times_NNS because_IN of_IN throughput_NN
          constraints_NNS ._.
          Why_WRB do_VBP we_PRP see_VBP differential_NN effects_NNS of_IN DAP_NNP ,_, MeC_NNP ,_, and_CC
          MeU_NNP on_IN hybridization_NN intensities_NNS ?_. The_DT fact_NN that_IN DAP_NNP was_VBD
          able_JJ to_TO increase_VB hybridization_NN intensities_NNS while_IN MeC_NNP and_CC
          MeU_NNP decreased_VBD hybridization_NN intensities_NNS (_( Figures_NNS 2_CD Dand_NNP
          2_CD E_NNP )_) is_VBZ interesting_JJ in_IN light_NN of_IN the_DT fact_NN that_IN DAP_NNP is_VBZ a_DT
          purine_NN incorporated_VBN into_IN an_DT RNA_NNP strand_NN while_IN MeC_NNP and_CC MeU_NNP
          are_VBP pyrimidines_NNS incorporated_VBN into_IN an_DT RNA_NNP strand_NN ._. Many_JJ
          studies_NNS have_VBP shown_VBN that_IN a_DT ribopurine_NN rich_JJ strand_NN bound_VBN to_TO
          a_DT deoxypyrimidine_NN rich_JJ strand_NN has_VBZ a_DT higher_JJR stability_NN than_IN
          the_DT corresponding_JJ all_DT deoxy_NN strands_NNS which_WDT ,_, in_IN turn_NN ,_, have_VBP
          a_DT higher_JJR stability_NN than_IN a_DT deoxypurine_NN rich_JJ strand_NN bound_VBN
          to_TO a_DT ribopyrimidine_NN rich_JJ strand_NN [_NN 26_CD 27_CD ]_NN ._. These_DT
          differences_NNS also_RB suggest_VBP that_IN further_JJ studies_NNS examining_VBG
          DAP_NNP or_CC MeC_NNP incorporation_NN into_IN first_JJ strand_NN cDNA_NN ,_, followed_VBN
          by_IN formation_NN of_IN a_DT DNA-DNA_NNP duplex_NN ,_, may_MD not_RB necessarily_RB
          show_VB the_DT same_JJ effects_NNS as_IN incorporation_NN of_IN these_DT modified_VBN
          nucleotides_NNS into_IN cRNA_NN ._. Finally_RB ,_, earlier_JJR studies_NNS have_VBP
          noted_VBN that_DT methylation_NN of_IN cytosines_NNS (_( generating_NN MeC_NNP )_) in_IN
          ribopolynucleotides_NNS stabilizes_VBZ duplexes_NNS to_TO the_DT same_JJ
          extent_NN as_IN substitution_NN of_IN thymine_NN (_( MeU_NNP )_) for_IN uracil_NN [_NN 28_CD ]_NN
          ._. Thus_RB ,_, although_IN it_PRP is_VBZ still_RB surprising_JJ that_IN MeC_NNP and_CC MeU_NNP
          decrease_VBP hybridization_NN intensities_NNS ,_, it_PRP is_VBZ not_RB surprising_VBG
          that_IN the_DT magnitude_NN of_IN the_DT effects_NNS generated_VBN by_IN MeC_NNP and_CC
          MeU_NNP residues_NNS are_VBP similar_JJ ._.
          Could_MD the_DT differential_NN effects_NNS of_IN DAP_NNP versus_CC MeC_NNP or_CC
          MeU_NNP or_CC the_DT differential_NN effects_NNS of_IN DAP_NNP on_IN different_JJ probe_NN
          sequences_NNS also_RB be_VB related_VBN to_TO structural_JJ consequences_NNS ?_.
          Earlier_JJR studies_NNS have_VBP shown_VBN that_IN DAP_NNP ,_, in_IN DNA_NNP fragments_NNS ,_,
          can_MD widen_VB the_DT minor_JJ groove_NN ,_, as_IN detected_VBN by_IN reactivity_NN
          towards_IN uranyl_NN nitrate_NN or_CC susceptibility_NN to_TO Dnase_NNP
          cleavage_NN [_NN 29_CD ]_NN ,_, and_CC can_MD relieve_VB compressions_NNS in_IN the_DT
          minor_JJ groove_NN associated_VBN with_IN A-_NNP tracts_NNS [_NN 30_CD ]_NN ._. In_IN
          contrast_NN ,_, NMR_NNP and_CC molecular_JJ modeling_NN studies_NNS of_IN an_DT
          oligonucleotide_NN duplex_NN containing_VBG MeC_NNP have_VBP demonstrated_VBN
          that_IN ,_, while_IN this_DT duplex_NN still_RB has_VBZ a_DT B-DNA_NNP conformation_NN ,_,
          there_EX are_VBP differences_NNS in_IN the_DT structural_JJ parameters_NNS and_CC
          thermal_JJ stability_NN relative_JJ to_TO the_DT unmodified_JJ duplex_NN [_NN 31_CD
          ]_NN ._. An_DT earlier_JJR study_NN also_RB found_VBD ,_, in_IN two_CD closely_RB related_VBN
          octanucleotide_NN duplexes_NNS ,_, that_IN although_IN the_DT methylated_JJ
          duplexes_NNS retained_VBD their_PRP$ B-DNA_NNP conformation_NN ,_, different_JJ
          structural_JJ and_CC thermal_JJ stability_NN effects_NNS were_VBD seen_VBN [_NN 32_CD ]_NN
          ._. Although_IN these_DT studies_NNS have_VBP been_VBN carried_VBN out_IN with_IN
          DNA-DNA_NNP and_CC not_RB DNA-RNA_NNP duplexes_NNS ,_, it_PRP is_VBZ possible_JJ that_IN MeC_NNP
          substitution_NN may_MD have_VB different_JJ structural_JJ consequences_NNS
          than_IN DAP_NNP substitution_NN ._.
          We_PRP have_VBP shown_VBN that_IN while_IN complete_JJ substitution_NN of_IN DAP_NNP
          for_IN ATP_NNP may_MD cause_VB decreased_VBD base_NN mismatch_NN discrimination_NN
          in_IN certain_JJ sequence_NN contexts_NNS ,_, equimolar_NN ratios_NNS of_IN
          adenosine_NN and_CC DAP_NNP in_IN cRNA_NN target_NN samples_NNS did_VBD not_RB have_VB
          significant_JJ detrimental_JJ effects_NNS on_IN specificity_NN (_( Figure_NN
          4_LS )_) ._. Remarkably_NNP ,_, in_IN one_CD sequence_NN context_NN ,_, the_DT DAP_NNP
          modification_NN enhanced_JJ specificity_NN against_IN mismatches_NNS ._.
          Enhanced_NNP specificity_NN against_IN mismatches_NNS has_VBZ also_RB been_VBN
          observed_VBN by_IN other_JJ groups_NNS when_WRB DAP_NNP is_VBZ incorporated_VBN into_IN
          PNA_NNP oligomers_NNS [_NN 13_CD ]_NN and_CC after_IN C_NNP 5_CD -_: (_( 1_CD -_: propynyl_NN )_) ation_NN of_IN
          pyrimidines_NNS in_IN DNA-RNA_NNP duplexes_NNS [_NN 33_CD ]_NN ._.
        
        
          The_DT effect_NN of_IN modified_VBN NTPs_NNP on_IN differential_NN
          expression_NN ratios_NNS
          The_DT use_NN of_IN DAP_NNP to_TO increase_VB hybridization_NN signals_NNS is_VBZ
          supported_VBN by_IN the_DT results_NNS that_WDT show_NN equivalency_NN of_IN both_DT
          ratio_NN calls_VBZ and_CC ratio_NN variability_NN in_IN 1_CD :_: 1_CD DAP_NNP :_: A_DT and_CC
          control_NN samples_NNS (_( Figures_NNS 5_CD and_CC 6_CD )_) ._. When_WRB all_DT data_NNS points_NNS
          are_VBP considered_VBN in_IN the_DT differential_NN expression_NN ratio_NN
          analyses_NNS ,_, the_DT two_CD methods_NNS appear_VBP equivalent_NN ._. However_RB ,_,
          when_WRB only_RB those_DT data_NNS points_NNS which_WDT are_VBP above_IN a_DT threshold_NN
          value_NN [_NN 6_CD ]_NN are_VBP used_VBN ,_, ensuring_VBG a_DT higher_JJR confidence_NN that_IN
          these_DT intensities_NNS represent_VBP true_JJ expression_NN levels_NNS and_CC
          not_RB noise_NN or_CC weak_JJ cross_NN hybridization_NN ,_, the_DT DAP-modified_NNP
          cRNA_NN enabled_VBD an_DT ~_NN 10_CD %_NN increase_NN in_IN the_DT number_NN of_IN ratios_NNS
          that_WDT could_MD be_VB generated_VBN (_( Figure_NN 7_CD )_) ._. Such_JJ increases_NNS are_VBP
          critical_JJ in_IN order_NN to_TO sample_NN as_IN many_JJ genes_NNS as_IN possible_JJ in_IN
          any_DT given_VBN microarray_NN experiment_NN ._. For_IN example_NN ,_, some_DT
          investigators_NNS have_VBP analyzed_VBN only_RB data_NNS for_IN which_WDT the_DT
          signal_NN intensity_NN is_VBZ greater_JJR than_IN approximately_RB 0_CD ._. 4_CD %_NN of_IN
          the_DT total_JJ signal_NN range_NN in_IN both_DT channels_NNS [_NN 34_CD ]_NN ._. Although_IN
          this_DT method_NN minimizes_NNS the_DT variance_NN associated_VBN with_IN the_DT
          ratios_NNS ,_, many_JJ genes_NNS and_CC their_PRP$ expression_NN changes_NNS are_VBP
          missed_VBN ._. Other_JJ platforms_NNS use_VBP a_DT minimal_JJ intensity_NN level_NN to_TO
          determine_VB whether_IN a_DT gene_NN is_VBZ present_JJ or_CC absent_JJ ,_, prior_RB to_TO
          including_VBG this_DT gene_NN in_IN expression_NN analyses_NNS [_NN 35_CD ]_NN ._. It_PRP is_VBZ
          plausible_JJ that_IN DAP_NNP modification_NN ,_, by_IN increasing_VBG intensity_NN
          levels_NNS ,_, particularly_RB for_IN low_JJ expressors_NNS ,_, could_MD enable_VB
          wider_JJR coverage_NN in_IN genome-wide_JJ expression_NN analyses_NNS ._.
          In_IN summary_NN ,_, incorporation_NN of_IN modified_VBN nucleotides_NNS may_MD
          not_RB only_RB lead_VB to_TO discovery_NN and_CC better_JJR quantitation_NN of_IN
          rare_JJ expressers_NNS in_IN complex_JJ samples_NNS but_CC also_RB impact_VB other_JJ
          aspects_NNS of_IN the_DT microarray_NN experiment_NN such_JJ as_IN probe_NN design_NN
          prior_RB to_TO array_NN fabrication_NN and_CC the_DT statistical_JJ design_NN of_IN
          microarray_NN experiments_NNS ._. The_DT target_NN preparation_NN procedure_NN
          (_( generation_NN of_IN amplified_VBN cRNA_NN or_CC of_IN first_JJ strand_NN cDNA_NN )_)
          and_CC the_DT subsequent_JJ duplex_NN formation_NN may_MD dictate_VB the_DT
          choice_NN of_IN which_WDT modified_VBN nucleotide_NN to_TO use_VB ,_, as_IN we_PRP and_CC
          others_NNS have_VBP found_VBN differential_NN effects_NNS with_IN various_JJ
          nucleotides_NNS ._. We_PRP believe_VBP further_JJ investigation_NN in_IN this_DT
          area_NN could_MD be_VB fruitful_JJ ._.
        
      
      
        Methods_NNP
        
          Target_NNP preparation_NN
          Five_CD μgs_NNS of_IN human_JJ embryonic_JJ kidney_NN or_CC Burkitt_NNP 's_POS
          lymphoma_NN total_JJ RNA_NNP (_( Ambion_NNP ,_, Inc_NNP ._. ,_, Austin_NNP ,_, TX_NNP )_) were_VBD added_VBN
          to_TO a_DT reaction_NN mix_NN in_IN a_DT final_JJ volume_NN of_IN 12_CD μl_NN ,_, containing_VBG
          0_CD ._. 5_CD pmol_NN T_NN 7_CD -_: (_( dT_NN )_) 
          24_CD oligonucleotide_NN primer_NN ._. The_DT mixture_NN
          was_VBD incubated_JJ for_IN 10_CD minutes_NNS at_IN 70_CD °_NN C_NNP and_CC chilled_VBN on_IN ice_NN ._.
          With_IN the_DT mixture_NN remaining_VBG on_IN ice_NN ,_, 4_CD μl_NN of_IN 5_CD X_NNP
          first-strand_JJ buffer_NN ,_, 2_CD μl_NN 0_CD ._. 1_CD M_NNP DTT_NNP ,_, 1_CD μl_NN of_IN 10_CD mM_NN dNTP_NN
          mix_NN and_CC 1_CD μl_NN Superscript_NNP ™_NN II_NNP RNaseH_NNP -_: reverse_VB
          transcriptase_NN (_( 200_CD U_NNP /_NN μl_NN )_) was_VBD added_VBN to_TO make_VB a_DT final_JJ volume_NN
          of_IN 20_CD μl_NN ,_, and_CC the_DT mixture_NN incubated_JJ for_IN one_CD hour_NN in_IN a_DT
          42_CD °_NN C_NNP water_NN bath_NN ._. Second-strand_NNP cDNA_NN was_VBD synthesized_JJ in_IN a_DT
          final_JJ volume_NN of_IN 150_CD μl_NN ,_, in_IN a_DT mixture_NN containing_VBG 30_CD μl_NN of_IN
          5_CD X_NNP second-strand_JJ buffer_NN ,_, 3_CD μl_NN of_IN 10_CD mM_NN dNTP_NN mix_NN ,_, 4_CD μl_NN of_IN 
          E_NNP ._. coli_NNS DNA_NNP polymerase_NN I_PRP (_( 10_CD U_NNP /_NN μl_NN )_)
          and_CC 1_CD μl_NN of_IN RNase_NNP H_NNP (_( 2_CD U_NNP /_NN μl_NN )_) for_IN 2_CD hours_NNS at_IN 16_CD °_NN C_NNP ._. The_DT
          cDNA_NN was_VBD purified_JJ using_VBG a_DT Qiagen_NNP QIAquick_NNP purification_NN
          kit_NN ,_, dried_VBD down_RB ,_, and_CC resuspended_JJ in_IN IVT_NNP reaction_NN mix_NN ,_,
          containing_VBG 3_CD ._. 0_CD μl_NN nuclease-free_JJ water_NN ,_, 4_CD ._. 0_CD μl_NN 10_CD X_NNP
          reaction_NN buffer_NN ,_, 4_CD ._. 0_CD μl_NN 75_CD mM_NN ATP_NNP ,_, 4_CD ._. 0_CD μl_NN 75_CD mM_NN GTP_NNP 3_CD ._. 0_CD
          μl_NN 75_CD mM_NN CTP_NNP ,_, 3_CD ._. 0_CD μl_NN 75_CD mM_NN UTP_NNP ,_, 7_CD ._. 5_CD μl_NN 10_CD mM_NN
          Biotin-_NNP 11_CD -_: CTP_NNP ,_, 7_CD ._. 5_CD μl_NN 10_CD mM_NN Biotin_NNP 11_CD -_: UTP_NNP and_CC 4_CD ._. 0_CD μl_NN
          enzyme_NN mix_NN (_( unmodified_JJ control_NN condition_NN )_) ._. Commercially_NNP
          available_JJ 2_CD -_: aminoadenosine-_NN 5_CD '_POS -_: triphosphate_NN ,_,
          5_CD -_: methylcytidine-_NN 5_CD '_POS -_: triphosphate_NN ,_, and_CC
          5_CD -_: methyluridine-_NN 5_CD '_POS -_: triphosphate_NN (_( TriLink_NNP Biotechnologies_NNP ,_,
          Inc_NNP ._. ,_, San_NNP Diego_NNP ,_, CA_NNP )_) were_VBD substituted_VBN for_IN ATP_NNP ,_, CTP_NNP ,_, and_CC
          UTP_NNP ,_, respectively_RB ,_, in_IN separate_JJ reactions_NNS containing_VBG
          either_CC complete_JJ substitution_NN ,_, 1_CD :_: 1_CD ,_, or_CC 1_CD :_: 3_CD ratio_NN of_IN
          modified_VBN :_: unmodified_JJ NTP_NNP ,_, keeping_VBG molar_NN input_NN of_IN
          nucleotide_NN constant_JJ ._. The_DT reaction_NN mix_NN was_VBD incubated_JJ for_IN
          14_CD hours_NNS at_IN 37_CD °_NN C_NNP and_CC cRNA_NN target_NN purified_JJ using_VBG an_DT RNeasy_NNP
          ®_NN Kit_NNP (_( Qiagen_NNP )_) ._. cRNA_NN yield_NN was_VBD quantitated_JJ by_IN measuring_VBG
          the_DT UV_NNP absorbance_NN at_IN 260_CD nm_NN ,_, and_CC fragmented_JJ in_IN 40_CD mM_NN
          Tris-acetate_NNP (_( TrisOAc_NNP )_) ,_, pH_NN 7_CD ._. 9_CD ,_, 100_CD mM_NN KOAc_NNP ,_, and_CC 31_CD ._. 5_LS mM_NN
          MgOAc_NNP ,_, at_IN 94_CD °_NN C_NNP ,_, for_IN 20_CD minutes_NNS ._. This_DT typically_RB resulted_VBN
          in_IN fragmented_VBN target_NN with_IN a_DT size_NN range_NN between_IN 100_CD -_: 200_CD
          bases_NNS ._.
        
        
          Array_NNP hybridization_NN
          Two_CD μg_NN of_IN fragmented_JJ target_NN cRNA_NN was_VBD used_VBN for_IN
          hybridization_NN of_IN each_DT UniSet_NNP Human_NNP I_PRP Expression_NNP Bioarray_NNP
          (_( Motorola_NNP Life_NNP Sciences_NNPS )_) containing_VBG 9589_CD probes_NNS
          (_( representing_VBG 9_CD ,_, 203_CD unique_JJ accession_NN numbers_NNS (_( genes_NNS )_) ,_,
          corresponding_JJ to_TO approximately_RB 8_CD ,_, 935_CD unique_JJ clusters_NNS and_CC
          386_CD control_NN probes_NNS ,_, selected_VBD initially_RB from_IN GenBank_NNP
          Unigene_NNP build_VB #_# 125_CD )_) or_CC for_IN hybridization_NN to_TO a_DT microarray_NN
          containing_VBG probes_NNS corresponding_JJ to_TO 1100_CD human_JJ genes_NNS ,_, each_DT
          spotted_VBD 6_CD times_NNS per_IN array_NN ._. All_DT probes_NNS on_IN these_DT
          microarrays_NNS are_VBP 30_CD -_: mer_NN oligonucleotides_NNS spotted_VBN by_IN
          piezoelectric_JJ technologies_NNS and_CC covalently_RB attached_VBN to_TO a_DT
          polymeric_JJ matrix_NN [_NN 6_CD ]_NN ._. These_DT microarrays_NNS were_VBD
          hybridized_JJ ,_, washed_VBN ,_, and_CC processed_VBD using_VBG a_DT direct_JJ
          detection_NN method_NN of_IN the_DT biotin-containing_JJ transcripts_NNS by_IN
          a_DT Streptavidin-_NNP Alexa_NNP 647_CD conjugate_NN as_RB previously_RB described_VBD
          [_NN 6_CD ]_NN ._. Processed_NNP slides_NNS were_VBD scanned_JJ using_VBG an_DT Axon_NNP
          GenePix_NNP Scanner_NNP with_IN the_DT laser_NN set_VBN to_TO 635_CD nm_NN ,_, a_DT PMT_NNP
          voltage_NN of_IN 600_CD ,_, and_CC a_DT scan_VB resolution_NN of_IN 10_CD microns_NNS ._.
        
        
          Data_NNP analysis_NN
          Slides_NNS were_VBD scanned_JJ and_CC images_NNS for_IN each_DT slide_NN were_VBD
          quantitated_JJ using_VBG CodeLink_NNP Scanning_NNP and_CC Analysis_NNP Software_NNP
          (_( Motorola_NNP Life_NNP Sciences_NNPS )_) ._. Signal_NNP intensities_NNS for_IN each_DT
          spot_NN were_VBD calculated_VBN by_IN summation_NN of_IN the_DT pixel_NN
          intensities_NNS for_IN each_DT spot_NN ,_, followed_VBN by_IN local_JJ background_NN
          subtraction_NN (_( based_VBN on_IN the_DT median_JJ pixel_NN intensity_NN of_IN the_DT
          area_NN surrounding_VBG each_DT spot_NN )_) ._. Whole_JJ array_NN data_NNS
          normalization_NN ,_, when_WRB used_VBN ,_, was_VBD performed_VBN independently_RB for_IN
          each_DT slide_NN by_IN dividing_VBG each_DT spot_NN 's_POS intensity_NN (_( after_IN
          background_NN subtraction_NN )_) by_IN the_DT median_JJ signal_NN intensity_NN of_IN
          all_DT test_NN probes_NNS ._. All_DT false_JJ positives_NNS ,_, determined_VBN by_IN
          visual_JJ inspection_NN of_IN the_DT images_NNS ,_, which_WDT were_VBD greater_JJR than_IN
          2_CD -_: fold_VB different_JJ between_IN duplicate_VB arrays_NNS were_VBD
          removed_VBN ._.
        
        
          Digestion_NNP and_CC chromatography_NN of_IN cRNA_NN
          Four_CD units_NNS of_IN P_NN 1_CD nuclease_NN were_VBD used_VBN to_TO digest_VB 20_CD -_: 50_CD μg_NN
          of_IN cRNA_NN to_TO generate_VB nucleotide_NN monophosphates_NNS ._. The_DT enzyme_NN
          was_VBD incubated_JJ with_IN the_DT cRNA_NN at_IN 55_CD °_NN C_NNP for_IN 6_CD hours_NNS ,_, then_RB for_IN
          6_CD hours_NNS at_IN 37_CD °_NN C_NNP in_IN the_DT presence_NN of_IN 10_CD units_NNS of_IN calf_NN
          intestine_NN alkaline_NN phosphatase_NN to_TO generate_VB the_DT
          nucleosides_NNS ._. The_DT digested_VBN products_NNS were_VBD purified_JJ using_VBG
          Microcon_NNP YM-_NNP 3_CD columns_NNS followed_VBN by_IN centrifugation_NN at_IN 8000_CD 
          g_SYM for_IN 30_CD -_: 60_CD minutes_NNS ._. The_DT mix_NN was_VBD
          then_RB concentrated_VBN using_VBG a_DT SpeedVac_NNP to_TO 100_CD μl_NN ._. This_DT
          solution_NN was_VBD analyzed_VBN on_IN an_DT HPLC_NNP column_NN equilibrated_JJ with_IN
          0_CD ._. 03_CD M_NNP TEAA_NNP (_( Solvent_NNP A_DT )_) at_IN a_DT flow_NN rate_NN of_IN 1_CD ml_NN /_NN min_NN ._. The_DT
          following_VBG gradient_NN was_VBD used_VBN :_: 0_CD -_: 1_CD %_NN Solvent_NNP B_NNP (_( 95_CD %_NN AcCN_NNP ,_, 5_CD %_NN
          Solvent_NNP A_DT 1_LS )_) over_IN 5_CD minutes_NNS ,_, 1_CD -_: 15_CD %_NN Solvent_NNP B_NNP over_IN the_DT next_JJ
          15_CD minutes_NNS ,_, 15_CD -_: 45_CD %_NN Solvent_NNP B_NNP over_IN the_DT next_JJ 30_CD minutes_NNS ,_,
          45_CD -_: 100_CD %_NN Solvent_NNP B_NNP over_IN the_DT next_JJ 20_CD minutes_NNS ,_, and_CC hold_VB at_IN
          100_CD %_NN B_NNP for_IN 2_CD minutes_NNS ._. The_DT concentration_NN of_IN the_DT
          heterocycles_NNS was_VBD determined_VBN by_IN the_DT absorbance_NN values_NNS at_IN
          260_CD nm_NN (_( the_DT wavelength_NN where_WRB maximal_NN absorption_NN occurs_VBZ
          for_IN the_DT heterocycles_NNS )_) and_CC the_DT biotin-containing_JJ
          nucleoside_NN concentrations_NNS were_VBD determined_VBN by_IN the_DT
          absorbance_NN values_NNS at_IN 294_CD nm_NN (_( the_DT wavelength_NN where_WRB maximal_NN
          absorption_NN occurs_VBZ for_IN biotinylated_JJ cytosine_NN and_CC
          biotinylated_JJ uridine_NN )_) ._. The_DT biotin-_NN 11_CD -_: UTP_NNP peak_NN was_VBD
          measured_VBN at_IN an_DT absorbance_NN of_IN 294_CD nm_NN with_IN the_DT extinction_NN
          coefficient_NN =_SYM 13000_CD M_NNP -_: 1_CD cm_NN -_: 1_CD ._. The_DT 2_CD -_: amino_JJ ATP_NNP was_VBD
          measured_VBN at_IN an_DT absorbance_NN of_IN 260_CD nm_NN with_IN the_DT extinction_NN
          coefficient_NN =_SYM 9894_CD M_NNP -_: 1_CD cm_NN -_: 1_CD ._.
        
      
      
        Authors_NNP '_'' contributions_NNS
        AN_DT performed_VBD the_DT target_NN preparations_NNS ,_, microarray_NN
        hybridizations_NNS ,_, and_CC data_NNS analyses_NNS ,_, and_CC drafted_VBD the_DT
        manuscript_NN ._. CZ_NNP performed_VBD the_DT digestion_NN and_CC chromatography_NN
        of_IN the_DT cRNAs_NNS ._. DD_NNP participated_VBD in_IN design_NN of_IN the_DT study_NN and_CC
        data_NNS analyses_NNS ._. AM_NNP conceived_VBD the_DT study_NN ,_, participated_VBD in_IN its_PRP$
        design_NN and_CC coordination_NN ,_, and_CC aided_VBD in_IN drafting_VBG the_DT
        manuscript_NN ._.
      
    
  
